Buyout Desk
Platform

Morphosis Capital agrees to buy majority stake in Dr. Mrini Eye Hospital

Constanța-based eye hospital with turnover above EUR 5 million in 2025 will anchor a national ophthalmology network.

Romanian private equity firm Morphosis Capital has agreed to acquire a majority stake in Dr. Mrini Eye Hospital in Constanța through its second investment fund. The deal is subject to approvals from the Competition Council and foreign direct investment authorities. The value was not disclosed.

Dr. Mrini Eye Hospital was founded in 2011 by ophthalmic surgeon Hicham Mrini. The hospital recorded turnover of more than EUR 5 million in 2025 and operates a 30-bed day hospital, an outpatient clinic, optical retail services and a clinic in Tulcea. A recently completed extension of more than 1,200 sqm is expected to double its capacity. Hicham Mrini will retain a significant shareholding and continue to oversee medical operations.

Morphosis Capital plans to expand the network into major Romanian cities through acquisitions of existing ophthalmology clinics and new openings, and says talks are under way with several potential partners. Morphosis Capital Fund II is backed by the Romania Recovery Equity Fund and the EU's InvestEU programme.

Deal facts

Target
Dr. Mrini Eye Hospital
Business
Eye hospital and ophthalmology clinic operator in Constanța, Romania, with a 30-bed day hospital, outpatient clinic, optical retail and a clinic in Tulcea
Buyer
Morphosis Capital Fund II
Deal type
Platform
Headquarters
Constanța, Romania
Status
Announced
Announced
Monday, November 9, 2026

Sources

Written by Buyout Desk from the sources above. Spotted an error? Email corrections@buyoutdesk.com.